STAT5B and neoplasm: Most importantly, pharmacological Jak2-Stat5 blockade inhibited CR growth of PC xenograft tumors after ENZ resistance developed and induced further cell death in patient-derived PCs treated with ENZ ex vivo in tumor explant cultures [24].